Residency · Residency · Interventional Radiology

Cone-Beam CT in Interventional Radiology

Introduction

Cone-beam computed tomography (CBCT) is an advanced imaging capability integrated into modern angiographic systems that provides three-dimensional, cross-sectional imaging during interventional procedures. By performing a rotational acquisition with the C-arm, CBCT bridges the gap between fluoroscopic guidance and conventional CT, enabling real-time volumetric assessment without transferring the patient.

Physics and Image Acquisition

Principles of CBCT

A cone-shaped X-ray beam and flat-panel detector rotate around the patient, typically through a 200-degree arc. Multiple projection images (150-600 frames) are acquired during the rotation over 5-20 seconds. Volumetric data is reconstructed using a Feldkamp-Davis-Kress (FDK) filtered back-projection algorithm. Spatial resolution approaches 0.1-0.2 mm, superior to multidetector CT for high-contrast structures.

Acquisition Protocols

Non-contrast CBCT: assessment of device position, bony anatomy, or dense materials (e.g., lipiodol retention). Contrast-enhanced CBCT: selective arterial injection with delayed rotational acquisition to map tumor vascularity and perfusion. Dual-phase CBCT: arterial and delayed acquisitions to differentiate tumor enhancement from surrounding parenchyma.

Image Quality Considerations

Cone-beam artifacts: scatter, beam hardening, and truncation artifacts are more pronounced than in conventional CT. Motion artifacts from respiration can degrade image quality; breath-hold or respiratory gating is essential. Soft tissue contrast is inferior to multidetector CT due to increased scatter and limited dynamic range. Metal artifacts from coils, stents, or dense embolic material can obscure adjacent structures.

Clinical Applications

Hepatic Interventions

Transarterial chemoembolization (TACE): CBCT identifies feeding arteries to hepatocellular carcinoma and confirms completeness of lipiodol deposition. Radioembolization (Y-90): CBCT during mapping angiography verifies catheter position and detects extrahepatic perfusion. Intraprocedural CBCT changes management in up to 30% of TACE cases by identifying additional tumors or feeders not seen on DSA.

Percutaneous Procedures

Needle guidance: CBCT provides real-time confirmation of needle trajectory for biopsies, ablations, and drainages. Overlay of CBCT datasets onto live fluoroscopy creates 3D roadmaps for navigating complex anatomy. Particularly valuable for lesions not visible on fluoroscopy or ultrasound.

Vascular Interventions

Assessment of stent deployment and apposition in aortic endografts. Identification of endoleak sources following endovascular aneurysm repair. Evaluation of intracranial stent placement and coil packing in neurointerventional procedures.

Musculoskeletal Applications

Vertebroplasty/kyphoplasty: CBCT confirms cement distribution and detects early cement leakage. Assessment of screw placement in minimally invasive spine procedures. Guidance for sacroiliac joint and facet injections in challenging anatomy.

Dose Considerations

A single CBCT acquisition delivers approximately 3-10 mGy to the skin, comparable to 1-3 minutes of fluoroscopy. Cumulative dose increases significantly when multiple CBCT runs are performed. Dose reduction strategies include: Reducing number of projection images per rotation. Lowering mA and kVp settings when high-contrast structures are the target. Limiting the number of CBCT acquisitions to those that will change management.

Integration with Navigation Systems

CBCT datasets can be fused with preprocedural CT, MRI, or PET-CT for multimodality guidance. Electromagnetic navigation systems use CBCT-derived 3D maps for catheter tracking without continuous fluoroscopy. Augmented fluoroscopy overlays CBCT-derived vascular maps onto live imaging, reducing contrast and radiation exposure.

Limitations

Limited field of view compared to conventional CT (typically 25 cm or smaller). Longer acquisition time increases susceptibility to motion artifact. Inferior soft tissue contrast compared to multidetector CT. Requires a trained operator to optimize acquisition parameters and interpret volumetric data. Not a substitute for diagnostic CT in most clinical scenarios.

Key Clinical Pearls

CBCT during TACE can detect additional tumors missed on preprocedural imaging and DSA, changing treatment strategy in a significant proportion of cases. For Y-90 radioembolization, CBCT is essential for confirming catheter position and detecting non-target perfusion that could result in radiation injury to the lungs or GI tract. Breath-hold technique is critical for hepatic CBCT; even small respiratory motion degrades image quality and reduces diagnostic accuracy. When using CBCT for needle guidance, a single acquisition with 3D overlay can replace multiple fluoroscopic spot checks, potentially reducing overall dose.

References

1. Tacher V, Radaelli A, Lin M, Geschwind JF. How I Do It: Cone-Beam CT during Transarterial Chemoembolization for Liver Cancer. Radiology. 2015;274(2):320-334.
2. Wallace MJ, Kuo MD, Glaiberman C, et al. Three-Dimensional C-Arm Cone-Beam CT: Applications in the Interventional Suite. J Vasc Interv Radiol. 2009;20(7 Suppl):S523-S537.
3. Orth RC, Wallace MJ, Kuo MD. C-Arm Cone-Beam CT: General Principles and Technical Considerations for Use in Interventional Radiology. J Vasc Interv Radiol. 2008;19(6):814-820.
4. Meyer BC, Frericks BB, Voges M, et al. Visualization of Hypervascular Liver Lesions During TACE: Comparison of Angiographic C-Arm CT and MDCT. AJR Am J Roentgenol. 2008;190(4):W263-W269.

For the intern

At 3am, if CBCT is requested during an active procedure, your job is to ensure the patient can breath-hold, clear the field of view of unnecessary equipment, and coordinate with the technologist for acquisition timing—especially during hepatic interventions where respiratory motion ruins image quality. Check that the radiation badge log is updated and document the number of CBCT runs performed. Most protocol decisions (contrast timing, dual-phase acquisitions) should have been planned before the case started and don't need middle-of-the-night adjustments. If asked to interpret CBCT findings, focus on the immediate procedural question: catheter position, device deployment, or target lesion coverage. Full diagnostic reads can wait until morning rounds.

Common pitfalls

• Forgetting breath-hold coaching: Even 5mm of diaphragmatic excursion creates unusable images in hepatic CBCT. Have the patient practice breath-holds before the actual acquisition, not during it.

• Overusing CBCT for dose-insensitive questions: Don't acquire a 7 mGy CBCT to answer a question that two fluoroscopy spots (0.5 mGy total) would solve. Each rotation adds significant cumulative dose.

• Misinterpreting scatter artifacts as pathology: The hazy increased attenuation around dense metal (coils, lipiodol) is artifact, not residual tumor or hemorrhage. Compare to pre-deployment images if available.

• Ignoring field-of-view limitations: CBCT typically images only 25cm diameter. Bilateral kidney assessments or full aortic imaging may require repositioning the C-arm or accepting incomplete coverage.

Read this lecture as Markdown